180 related articles for article (PubMed ID: 26631442)
1. Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2015 Dec; 23(24):7535-42. PubMed ID: 26631442
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new derivatives of 21-imidazolyl-16-dehydropregnenolone as inhibitors of 5α-reductase 2 and with cytotoxic activity in cancer cells.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan T; Heuze Y; Soriano J; Moreno I; Bravo M; Bautista L; Cabeza M
Bioorg Med Chem; 2017 Mar; 25(5):1600-1607. PubMed ID: 28174065
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062
[TBL] [Abstract][Full Text] [Related]
5. Activity of steroid 4 and derivatives 4a-4f as inhibitors of the enzyme 5α-reductase 1.
Arellano Y; Bratoeff E; Heuze Y; Bravo M; Soriano J; Cabeza M
Bioorg Med Chem; 2018 Aug; 26(14):4058-4064. PubMed ID: 30007568
[TBL] [Abstract][Full Text] [Related]
6. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
[TBL] [Abstract][Full Text] [Related]
7. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of two pregnane derivatives with a triazole or imidazole ring at C-21.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan MT; García-Becerra R; Ordaz-Rosado D; Noyola-Martínez N; Castillo-Bocanegra R; Barrera D
J Steroid Biochem Mol Biol; 2016 May; 159():8-18. PubMed ID: 26924581
[TBL] [Abstract][Full Text] [Related]
9. Effect of dehydroepiandrosterone derivatives on the activity of 5α-reductase isoenzymes and on cancer cell line PC-3.
Bratoeff E; Garrido M; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2014 Nov; 22(21):6233-41. PubMed ID: 25261928
[TBL] [Abstract][Full Text] [Related]
10. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors.
Arellano Y; Bratoeff E; Garrido M; Soriano J; Heuze Y; Cabeza M
Steroids; 2011 Nov; 76(12):1241-6. PubMed ID: 21729714
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effect of androstene derivatives as 5α-reductase type 1 enzyme inhibitors.
Bratoeff E; Sánchez A; Arellano Y; Heuze Y; Soriano J; Cabeza M
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1247-54. PubMed ID: 23051174
[TBL] [Abstract][Full Text] [Related]
12. New steroidal lactones as 5α-reductase inhibitors and antagonists for the androgen receptor.
Garrido M; Bratoeff E; Bonilla D; Soriano J; Heuze Y; Cabeza M
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):367-73. PubMed ID: 21782943
[TBL] [Abstract][Full Text] [Related]
13. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
14. Novel dehydroepiandrosterone benzimidazolyl derivatives as 5α-reductase isozymes inhibitors.
Arellano Y; Bratoeff E; Segura T; Mendoza ME; Sánchez-Márquez A; Medina Y; Heuze Y; Soriano J; Cabeza M
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):908-14. PubMed ID: 26394987
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists.
Lao K; Xun G; Gou X; Xiang H
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1597-1606. PubMed ID: 31469015
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors.
Aggarwal S; Mahapatra MK; Kumar R; Bhardwaj TR; Hartmann RW; Haupenthal J; Kumar M
Bioorg Med Chem; 2016 Feb; 24(4):779-88. PubMed ID: 26780831
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, 17α-hydroxylase-C
Banday AH; Shameem SA; Banday JA; Ganaie BA
Anticancer Agents Med Chem; 2018; 18(13):1919-1926. PubMed ID: 29697032
[TBL] [Abstract][Full Text] [Related]
18. Steroidal pyrazolines and pyrazoles as potential 5α-reductase inhibitors: synthesis and biological evaluation.
Banday AH; Shameem SA; Jeelani S
Steroids; 2014 Dec; 92():13-9. PubMed ID: 25278254
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach.
Aggarwal S; Thareja S; Bhardwaj TR; Haupenthal J; Hartmann RW; Kumar M
Eur J Med Chem; 2012 Aug; 54():728-39. PubMed ID: 22776417
[TBL] [Abstract][Full Text] [Related]
20. [17(20)E]- and [17(20)Z]-pregna-5,17(20)-dien-21-oylamides. Facile synthesis and primary evaluation for cancer cells proliferation.
Stulov SV; Zavialova MG; Mehtiev AR; Novikov RA; Tkachev YV; Timofeev VP; Misharin AY
Bioorg Med Chem Lett; 2010 Sep; 20(18):5495-8. PubMed ID: 20702093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
